Understanding how HDL metabolism affects heart disease
Mentoring Patient-Oriented Research in Deep Lipid Phenotyping for Cardiovascular Disease
This study is looking at how good cholesterol (HDL) affects heart health, especially in South Asian people, to help find better ways to predict and treat heart disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-11004035 on NIH RePORTER |
What this research studies
This research focuses on the role of high-density lipoprotein (HDL) metabolism in cardiovascular disease, particularly in the South Asian population. Led by Dr. Anand Rohatgi, the project combines clinical cardiology with translational research to explore how HDL-related markers can predict heart disease risk and serve as potential therapy targets. The research involves mentoring trainees and faculty to advance knowledge in this area, with a strong emphasis on preventive cardiology. Patients may benefit from improved risk assessment and treatment strategies based on HDL metabolism insights.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for cardiovascular disease, particularly those from the South Asian population.
Not a fit: Patients with established cardiovascular disease or those not at risk for heart disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better risk prediction and targeted therapies for cardiovascular disease.
How similar studies have performed: Previous research has shown promising results in understanding HDL metabolism and its implications for cardiovascular health, indicating that this approach has potential for significant advancements.
Where this research is happening
Dallas, United States
- Ut Southwestern Medical Center — Dallas, United States (Active)
Researchers
- Principal investigator: Rohatgi, Anand Kumar — Ut Southwestern Medical Center
- Study coordinator: Rohatgi, Anand Kumar
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.